View the full study published in Toxicology Reports here.
A new study published by an international team of researchers proposes that the weight of evidence is AGAINST vaccinating children with experimental and sometimes lethal COVID-19 vaccines when the risks to their health far outweigh their purported benefits.
A newly published study in Toxicology Reports titled, "Why are we vaccinating children against COVID-19?," challenges the dominant narrative being widely promulgated throughout both the mainstream media and the world's governmental health authorities, namely, that vaccines are universally and a priori "safe and effective," despite an accumulating body of evidence on both the US government's VAERS and the WHO's VIGIBASE databases that the COVID-19 vaccines are causing unpredented harm to the public -- which, if true, is in direct violation of the medical ethical principle of informed consent.
The new study conducted by an international team of researchers, from 5 countries, is summarized in the abstract as follows:
"This article examines issues related to COVID-19 inoculations for children. The bulk of the official COVID-19-attributed deaths per capita occur in the elderly with high comorbidities, and the COVID-19 attributed deaths per capita are negligible in children. The bulk of the normalized post-inoculation deaths also occur in the elderly with high comorbidities, while the normalized post-inoculation deaths are small, but not negligible, in children. Clinical trials for these inoculations were very short-term (a few months), had samples not representative of the total population, and for adolescents/children, had poor predictive power because of their small size. Further, the clinical trials did not address changes in biomarkers that could serve as early warning indicators of elevated predisposition to serious diseases. Most importantly, the clinical trials did not address long-term effects that, if serious, would be borne by children/adolescents for potentially decades.
A novel best-case scenario cost-benefit analysis showed very conservatively that there are five times the number of deaths attributable to each inoculation vs those attributable to COVID-19 in the most vulnerable 65+ demographic. The risk of death from COVID-19 decreases drastically as age decreases, and the longer-term effects of the inoculations on lower age groups will increase their risk-benefit ratio, perhaps substantially."
If it is true that there are at least 5 times more deaths in elderly vaccinated individuals versus those who are believed to be infected with COVID-19, and if the risk of death from COVID-19 decreases drastically as the age decreases, clearly the risk-benefit analysis of vaccinating children shows far more risk than benefit. Vaccination of children, therefore, is not warranted if we are keeping their health and best interest in mind.
Additional highlights of the study are as follows:
•Bulk of COVID-19 per capita deaths occur in elderly with high comorbidities. •Per capita COVID-19 deaths are negligible in children.
•Clinical trials for these inoculations were very short-term.
•Clinical trials did not address long-term effects most relevant to children.
•High post-inoculation deaths reported in VAERS (very short-term).
The conclusions of these researchers echo sentiments recently shared by Steven Kirsh, Executive Director of the Covid-19 Early Treatment Fund, who told the FDA in an open hearing on COVID-19 boosters that occurred on Sept 17th, 2021, that the "Pfizer vaccine kills more than it saves." You can watch his testimony below.
Full Video: Vaccines and Related Biological Products Advisory Committee – 9/17/2021 https://www.youtube.com/watch?v=WFph7-6t34M